On June 6, 2017, Bio-Rad launched a RT-PCR kit that allows researchers to simultaneously screen samples for Zika, dengue, and chikungunya arbovirus RNAs. The assay comes with the controls researchers need to internally validate the results. According to the company , this assay is approved foOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.